About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

The Coronary Intravascular Lithotripsy System

Citation:

Interventional Cardiology Review 2019;14(3):174–81.

Rotational Atherectomy: A Contemporary Appraisal

Citation:

Interventional Cardiology Review 2019;14(3):182–9.

Patient Selection and Procedural Considerations for Coronary Orbital Atherectomy System

Citation:

Interventional Cardiology Review 2016;11(1):33–8

Intravascular Photoacoustic Imaging of Vulnerable Atherosclerotic Plaque

Citation:

Interventional Cardiology Review 2016;11(2):120–3